CN
112-99-2
应用筛选条件
关键词:'112-99-2'
显示 1-30 共 130 条结果 关于 "112-99-2" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
86 88 99 83 37 104 104 105 2 21 9
PRAK 81 104 91 6 36 93 71 108 112 88 85 68 51 74 76 104 96 98 89
PKA 2 91 35 17 94 95
Verfication summary-03-0202-00
MRD (1:2) 56.40 1.0 2% 112.80 1.0 1% -
3 1:4 31.71 1.1 3% 126.84 1.1 1% 112%
3 1:8 15.82 1.0 6% 126.59 1.0 1% 112%
3 1:16 8.04 0.1 2% 128.61 0.1 0% 114%
2822620
Verfication summary-03-0202-00
MRD (1:2) 56.40 1.0 2% 112.80 1.0 1% -
3 1:4 31.71 1.1 3% 126.84 1.1 1% 112%
3 1:8 15.82 1.0 6% 126.59 1.0 1% 112%
3 1:16 8.04 0.1 2% 128.61 0.1 0% 114%
2822620
The Effective Use of Protein Kinase Inhibitors
86 88 99 83 37 104 104 105 2 21 9
PRAK 81 104 91 6 36 93 71 108 112 88 85 68 51 74 76 104 96 98 89
PKA 2 91 35 17 94 95
(G3782) - Enzyme Assay
potassium phosphate,
2.3 mM o-nitrophenyl β-D-galactopyranoside, 1.0 mM magnesium chloride,
112 mM 2-mercaptoethanol and 0.20 - 0.40 unit β-galactosidase.
REFERENCE:
Craven, G.R., Steers
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
mL
Control 2 464 – 963 pg/mL Control 2 475 – 987 pg/mL
IFN-γ Control 1 112 – 232 pg/mL
(G4155) - Enzyme Assay
concentrations are 93 mM sodium phosphate,
2.3 mM o-QLWURSKHQ\O� �'�galactoside, 1.0 mM magnesium chloride, 112 mM 2-mercaptoethanol
DQG������������XQLW� �galactosidase.
REFERENCE:
Craven, G.R., Steers, E.
(G6008) - Enzyme Assay
concentrations are 93 mM sodium phosphate,
2.3 mM o-QLWURSKHQ\O� �'�galactoside, 1.0 mM magnesium chloride, 112 mM 2-mercaptoethanol
DQG������������XQLW� �galactosidase.
REFERENCE:
Craven, G.R., Steers, E.
(G2513) - Enzyme Assay
concentrations are 93 mM sodium phosphate,
2.3 mM o-QLWURSKHQ\O� �'�galactoside, 1.0 mM magnesium chloride, 112 mM 2-mercaptoethanol
DQG������������XQLW� �galactosidase.
REFERENCE:
Craven, G.R., Steers, E.
(G1875) - Enzyme Assay
concentrations are 93 mM sodium phosphate,
2.3 mM o-QLWURSKHQ\O� �'�galactoside, 1.0 mM magnesium chloride, 112 mM 2-mercaptoethanol
DQG������������XQLW� �galactosidase.
REFERENCE:
Craven, G.R., Steers, E.
(G5635) - Enzyme Assay
concentrations are 93 mM sodium phosphate,
2.3 mM o-QLWURSKHQ\O� �'�galactoside, 1.0 mM magnesium chloride, 112 mM 2-mercaptoethanol
DQG������������XQLW� �galactosidase.
REFERENCE:
Craven, G.R., Steers, E.
Quality Control Ranges: MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel
pg/mL IL-15 Control 1 102 - 212 pg/mL RANTES Control 1 112 - 232 pg/mL
Control 2 509 - 1056 pg/mL Control 2 527 - 1094 pg/mL Control 2 507 -
Anti-Mucin MUC5AC, clone CLH2 - Data Sheet
www.chemicon.com • custserv@chemicon.com • techserv@chemicon.com
7-20-99/MAB2011/TL/110304/ef
REFERENCES: Int’l. J. Cancer (1997) 74: 112.
Important Note: During shipment, small volumes
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Control 2 536 - 1113 pg/mL Control 2 561 - 1165 pg/mL
Eotaxin Control 1 99 - 206 pg/mL IL-13 Control 1 105 -
MOUSE ANTI-SEROTONIN TRANSPORTER
REFERENCES: Salli, et al., Exp. Neurology (2004) 188(2):351-364.
Henry, et al., JBC (2003) 278(39):37052-63.
Serafeim, et al., Blood (2002) 99(7):2545-2553.
Ramsey, et al., JBC (2002) 277(17):14475
Product Information Sheet - S5751
formulation factors
and mathematical equations fitted drug release
rates. Eur. J. Pharm. Sci., 19(2-3), 99-104 (2003).
GCY/RXR 12/03
Sigma brand products are sold through Sigma-Aldrich, Inc
Data Sheet - M253
glomerular MCP-1 expression in a model of
mesangial proliferative glomerulonephritis.” Exp.
Nephrol. 6, 112-120 (1998).
SMS 6/00
ProductInformation
Sigma brand products are sold through Sigma-Aldrich
Quality Control Range Sheet- A60MG-105 and A60MG-205
3000 pg/ml
Control 2 6811 - 14145 pg/ml
MIG/CXCL9 Control1 140 - 291 pg/ml
Control 2 735 - 1526 pg/ml
Data Sheet - S8695
J.D., et al., J. Cell Sci., 112, 2125-
2136 (1999).
6. Chen, Y., et al., J. Biol. Chem., 278, 46094-
46106 (2003).
7. Ting, H., et al., Proc. Nat. Acad. Sci. USA, 99,
661-666 (2002).
Data Sheet - N6288
Natl. Acad. Sci. USA, 84,
1472-1476 (1987).
2. Srivastava, M., et al., FEBS Lett., 250, 99-105
(1989).
3. Ginisty, H., et al., J. Cell Sci., 112, 761-772 (1999).
4. Srivastava, M., and Pollard
Quality Control Range Sheet- A6602-106 and A6602-206
pg/mL
Control 2 398 – 827 pg/mL Control 2 99 – 206 pg/mL
GROα Control 1 35 – 72 pg/mL IL-8 Control 1
Data Sheet - S4947
A., et al., Structure, 15, 377-389 (2007).
12. Mahlknecht, U., et al., Cytogenet. Genome Res.,
112, 208-212 (2006).
ST,CS,PHC 10/07-1
Sigma brand products are sold through Sigma-Aldrich, Inc.
Sigma-Aldrich
Product Information Sheet - SE120011
98 65 120
0.05 104 98 102 104 101 72 112
0.10 100 92
Monoclonal Anti-Bcl-2a antibody produced in mouse (B1809)
Reed, J.C., et al., Structure-function analysis of
Bcl-2 family proteins. Regulators of programmed
cell death. Adv. Exp. Med. Biol., 406, 99-112
(1996).
7. Rajah, R., et al., Insulin-like growth
Data Sheet - N2662
Natl. Acad. Sci. USA, 84,
1472-1476 (1987).
2. Srivastava, M., et al., FEBS Lett, 250, 99-105
(1989).
3. Ginisty, H., et al., J. Cell Sci., 112, 761-772
(1999).
4. Srivastava, M., and Pollard
Data Sheet - A4325
Ungewickell, E., J. Biol. Chem.,
267, 16567 (1992).
6. Robinson, M., Trends Cell Biol., 2, 293 (1992).
Pcs11/99
Panorama Ab Microarray - Gene Regulation I List of Antibodies
C7736
111 Coilin
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
extranuclear factor
50 1 50 1 50 1 50 1 50 1 49 1
IPI00298971 Vitronectin precursor 51 1 112 2 99 2
IPI00329547 Zinc finger CCCH domain-containing protein 13 50 1 50 1 50 1 50
Protocol
Serum 2 50 17.7 17.7
25 9.5 19.0 108
12.5 4.9 19.6 111
6.25 2.5 20.2 114
Serum 3 50 20.3
GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor
et al., J. Cell Sci., 111, 2445-2453 (1998).
111. Jinno, S., et al., EMBO J., 13, 1549-1556 (1994).
112. Galaktionov, K., et al., Science, 269, 1575-1577 (1995).
113 Ma, Z.Q., et al., Oncogene, 18, 4564-
1/5